Return To Office: Pfizer To Enforce 2-3 Days In Office Starting January

Return To Office: Pfizer To Enforce 2-3 Days In Office Starting January
  • Pfizer Inc's PFE CEO Albert Bourla said the U.S. employees would have to return to their workplaces two to three days a week starting in January.
  • About one-third of Pfizer's employees have still not returned to the office as concerns about the pandemic have begun fading, Bourla said in a panel discussion at the Paley International Council Summit in New York. 
  • Pfizer joined forces with BioNTech SE BNTX to develop one of the first COVID-19 vaccines at top speed during the pandemic when many employees were working from home and then generated the Paxlovid pill for treating people at high risk of severe disease. 
  • Both products have been highly successful for the company.
  • Related: Pfizer's Q3 Earnings Surpasses Estimates, Lifts Forecasts For COVID-19 Vaccine Sales By $2B.
  • "I started to worry we were going to lose the DNA of our company, the feeling of family," Bourla said in the discussion. "For our workforce, people with office-type jobs, we are asking them, and will start enforcing a two to three days" of weekly attendance, he said.
  • "We're trying to see how we can play our cards so that we can save the world once again," Bourla said. 
  • Price Action: PFE shares are down 0.55% at $47.09 during the premarket session on the last check Wednesday.

Posted In: BriefsBiotechLarge CapNewsHealth CareGeneral